OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Engineering Nano‐Therapeutics to Boost Adoptive Cell Therapy for Cancer Treatment
Chunxiong Zheng, Jiabin Zhang, Hon Fai Chan, et al.
Small Methods (2021) Vol. 5, Iss. 5
Closed Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Smart nanoparticles for cancer therapy
Leming Sun, Hongmei Liu, Yanqi Ye, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 375

A Biomimetic Aggregation‐Induced Emission Photosensitizer with Antigen‐Presenting and Hitchhiking Function for Lipid Droplet Targeted Photodynamic Immunotherapy
Xiuli Xu, Guanjun Deng, Zhihong Sun, et al.
Advanced Materials (2021) Vol. 33, Iss. 33
Closed Access | Times Cited: 128

Challenges and Opportunities of Nanomedicines in Clinical Translation
Chunxiong Zheng, Mingqiang Li, Jianxun Ding
BIO Integration (2021) Vol. 2, Iss. 2
Open Access | Times Cited: 124

The quest for nanoparticle-powered vaccines in cancer immunotherapy
Zhe Sun, Hui Zhao, Li Ma, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 27

Liposomes as Immunotherapeutic Carriers: A Game-Changer in Cancer Therapy
Sepehr Hoseinzadeh Moghaddam, Abulfazl Vatankhah, Fatemeh Oroojalian, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106847-106847
Closed Access | Times Cited: 3

Advanced Nanotheranostics of CRISPR/Cas for Viral Hepatitis and Hepatocellular Carcinoma
Huimin Kong, Enguo Ju, Ke Yi, et al.
Advanced Science (2021) Vol. 8, Iss. 24
Open Access | Times Cited: 63

Nano Drug Delivery System for Tumor Immunotherapy: Next-Generation Therapeutics
Lili Zhou, Manshu Zou, Yilin Xu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 50

Membrane‐Fusion‐Mediated Multiplex Engineering of Tumor Cell Surface Glycans for Enhanced NK Cell Therapy
Chunxiong Zheng, Qingguo Zhong, Wantong Song, et al.
Advanced Materials (2022) Vol. 35, Iss. 14
Closed Access | Times Cited: 43

Anti–phagocytosis-blocking repolarization-resistant membrane-fusogenic liposome (ARMFUL) for adoptive cell immunotherapy
Chunxiong Zheng, Qingguo Zhong, Ke Yi, et al.
Science Advances (2023) Vol. 9, Iss. 32
Open Access | Times Cited: 28

Self-intensified synergy of a versatile biomimetic nanozyme and doxorubicin on electrospun fibers to inhibit postsurgical tumor recurrence and metastasis
Yongwei Hu, Yanteng Xu, Rachel L. Mintz, et al.
Biomaterials (2022) Vol. 293, pp. 121942-121942
Closed Access | Times Cited: 35

A Fluorinated Supramolecular Self‐Assembled Peptide as Nanovaccine Adjuvant for Enhanced Cancer Vaccine Therapy
Shaorui Jia, Shenglu Ji, Jia Zhao, et al.
Small Methods (2023) Vol. 7, Iss. 5
Closed Access | Times Cited: 21

MicroRNA-122-functionalized DNA tetrahedron stimulate hepatic differentiation of human mesenchymal stem cells for acute liver failure therapy
Hongyan Wei, Fenfang Li, Tiantian Xue, et al.
Bioactive Materials (2023) Vol. 28, pp. 50-60
Open Access | Times Cited: 21

Immunotherapy Innovations in the Fight against Osteosarcoma: Emerging Strategies and Promising Progress
Shigao Cheng, Huiyuan Wang, Xuejia Kang, et al.
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 251-251
Open Access | Times Cited: 7

Nanodrug Delivery Systems in Antitumor Immunotherapy
Zishuo Guo, Jinhong Ye, Xuehao Cheng, et al.
Biomaterials Research (2024) Vol. 28
Open Access | Times Cited: 7

Delivery of Stem Cell Secretome for Therapeutic Applications
Fenfang Li, Jiabin Zhang, Ke Yi, et al.
ACS Applied Bio Materials (2022) Vol. 5, Iss. 5, pp. 2009-2030
Closed Access | Times Cited: 23

Membrane-fusogenic biomimetic particles: a new bioengineering tool learned from nature
Huimin Kong, Ke Yi, Chunxiong Zheng, et al.
Journal of Materials Chemistry B (2022) Vol. 10, Iss. 36, pp. 6841-6858
Closed Access | Times Cited: 20

Enhancing Skin Cancer Immunotheranostics and Precision Medicine through Functionalized Nanomodulators and Nanosensors: Recent Development and Prospects
Aisha Farhana
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3493-3493
Open Access | Times Cited: 13

Shifting cold to hot tumors by nanoparticle-loaded drugs and products
Irfan Ahmad, Kamil K. Atiyah Altameemi, Mohaned Mohammed Hani, et al.
Clinical & Translational Oncology (2024)
Closed Access | Times Cited: 4

Enhanced Intracellular Delivery via a Titanium-Coated TiO2 Microstructure Device: Leveraging an Infrared Laser for Optimal Efficiency
Ashwini Shinde, Anand Kumar Patel, Nitish R. Mahapatra, et al.
ACS Applied Materials & Interfaces (2025)
Closed Access

Multidimensional profiling of functionalized photothermal nanoplatforms for synergistic cancer immunotherapy: Design, strategy, and challenge
Wei Xiao, Mingzhu Song, Guanghao Jin, et al.
Coordination Chemistry Reviews (2023) Vol. 499, pp. 215488-215488
Closed Access | Times Cited: 9

Gold-seaurchin based immunomodulator enabling photothermal intervention and αCD16 transfection to boost NK cell adoptive immunotherapy
Xinyi Lin, Feida Li, Qing Gu, et al.
Acta Biomaterialia (2022) Vol. 146, pp. 406-420
Closed Access | Times Cited: 12

Enhancing Cancer Immunotherapeutic Efficacy with Sonotheranostic Strategies
Ayesha Zafar, Murtaza Hasan, Tuba Tariq, et al.
Bioconjugate Chemistry (2021) Vol. 33, Iss. 6, pp. 1011-1034
Closed Access | Times Cited: 16

Page 1 - Next Page

Scroll to top